Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials

Dave Singh, Italo Poggesi, Stephen Weng, David Slade, Laura Clow, Andrew Patterson, Litza McKenzie, Beth Brickhill, Christopher Roe, Emin Ibrahimov, Job van der Palen, Alison Donald, Maximilian Plank

Open source

DOI
10.1016/j.rmed.2026.109053
Published
2026-10
Container
Respiratory Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2026.109053,
  title = {Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials},
  author = {Dave Singh and Italo Poggesi and Stephen Weng and David Slade and Laura Clow and Andrew Patterson and Litza McKenzie and Beth Brickhill and Christopher Roe and Emin Ibrahimov and Job van der Palen and Alison Donald and Maximilian Plank},
  year = {2026},
  journal = {Respiratory Medicine},
  doi = {10.1016/j.rmed.2026.109053},
  url = {https://doi.org/10.1016/j.rmed.2026.109053}
}

RIS

TY  - JOUR
TI  - Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials
AU  - Dave Singh
AU  - Italo Poggesi
AU  - Stephen Weng
AU  - David Slade
AU  - Laura Clow
AU  - Andrew Patterson
AU  - Litza McKenzie
AU  - Beth Brickhill
AU  - Christopher Roe
AU  - Emin Ibrahimov
AU  - Job van der Palen
AU  - Alison Donald
AU  - Maximilian Plank
PY  - 2026
JO  - Respiratory Medicine
DO  - 10.1016/j.rmed.2026.109053
UR  - https://doi.org/10.1016/j.rmed.2026.109053
ER  - 

APA

Singh, D., Poggesi, I., Weng, S., Slade, D., Clow, L., Patterson, A., McKenzie, L., Brickhill, B., Roe, C., Ibrahimov, E., Palen, J. V. D., Donald, A., & Plank, M. (2026). Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109053

Source records